Science 11 September 1987: Vol. 237. no. 4820, pp. 1351 - 1355 DOI: 10.1126/science.3629244

Prev | Table of Contents | Next

Articles

Reconstitution of the Ancestral Glycoprotein of Human Endogenous Retrovirus K and Modulation of Its Functional Activity by Truncation of the Cytoplasmic Domain.

K. Hanke, P. Kramer, S. Seeher, N. Beimforde, R. Kurth, and N. Bannert (2009)
J. Virol. 83, 12790-12800
 |  Abstract »  |  Full Text »  |  PDF »

Truncation of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Defines Elements Required for Fusion, Incorporation, and Infectivity.

L. Yue, L. Shang, and E. Hunter (2009)
J. Virol. 83, 11588-11598
 |  Abstract »  |  Full Text »  |  PDF »

Derivation and Characterization of a Simian Immunodeficiency Virus SIVmac239 Variant with Tropism for CXCR4.

G. Q. Del Prete, B. Haggarty, G. J. Leslie, A. P. O. Jordan, J. Romano, N. Wang, J. Wang, M. C. Holmes, D. C. Montefiori, and J. A. Hoxie (2009)
J. Virol. 83, 9911-9922
 |  Abstract »  |  Full Text »  |  PDF »

Stable Docking of Neutralizing Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Monoclonal Antibodies 2F5 and 4E10 Is Dependent on the Membrane Immersion Depth of Their Epitope Regions.

S. M. Dennison, S. M. Stewart, K. C. Stempel, H.-X. Liao, B. F. Haynes, and S. M. Alam (2009)
J. Virol. 83, 10211-10223
 |  Abstract »  |  Full Text »  |  PDF »

Engineering an ultra-stable affinity reagent based on Top7.

C. B. Boschek, D. O. Apiyo, T. A. Soares, H. E. Engelmann, N. B. Pefaur, T. P. Straatsma, and C. L. Baird (2009)
Protein Eng. Des. Sel. 22, 325-332
 |  Abstract »  |  Full Text »  |  PDF »

Role of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein in Cell-Cell Fusion and Virus Infection.

L. Shang, L. Yue, and E. Hunter (2008)
J. Virol. 82, 5417-5428
 |  Abstract »  |  Full Text »  |  PDF »

Predicting proteolytic sites in extracellular proteins: only halfway there.

Y. Kliger, E. Gofer, A. Wool, A. Toporik, A. Apatoff, and M. Olshansky (2008)
Bioinformatics 24, 1049-1055
 |  Abstract »  |  Full Text »  |  PDF »

Identification and Characterization of UK-201844, a Novel Inhibitor That Interferes with Human Immunodeficiency Virus Type 1 gp160 Processing.

W. S. Blair, J. Cao, L. Jackson, J. Jimenez, Q. Peng, H. Wu, J. Isaacson, S. L. Butler, A. Chu, J. Graham, et al. (2007)
Antimicrob. Agents Chemother. 51, 3554-3561
 |  Abstract »  |  Full Text »  |  PDF »

The Neutralization Properties of a HIV-Specific Antibody Are Markedly Altered by Glycosylation Events Outside the Antigen-Binding Domain.

L. R. Miranda, M. Duval, H. Doherty, M. S. Seaman, M. R. Posner, and L. A. Cavacini (2007)
J. Immunol. 178, 7132-7138
 |  Abstract »  |  Full Text »  |  PDF »

Antibody Binding Is a Dominant Determinant of the Efficiency of Human Immunodeficiency Virus Type 1 Neutralization.

X. Yang, I. Lipchina, S. Cocklin, I. Chaiken, and J. Sodroski (2006)
J. Virol. 80, 11404-11408
 |  Abstract »  |  Full Text »  |  PDF »

Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.

G. Frey, S. Rits-Volloch, X.-Q. Zhang, R. T. Schooley, B. Chen, and S. C. Harrison (2006)
PNAS 103, 13938-13943
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain..

A. Duda, D. Luftenegger, T. Pietschmann, and D. Lindemann (2006)
J. Virol. 80, 8158-8167
 |  Abstract »  |  Full Text »  |  PDF »

The HIV-Neutralizing Monoclonal Antibody 4E10 Recognizes N-Terminal Sequences on the Native Antigen..

C. Hager-Braun, H. Katinger, and K. B. Tomer (2006)
J. Immunol. 176, 7471-7481
 |  Abstract »  |  Full Text »  |  PDF »

An Unrelated Monoclonal Antibody Neutralizes Human Immunodeficiency Virus Type 1 by Binding to an Artificial Epitope Engineered in a Functionally Neutral Region of the Viral Envelope Glycoproteins.

X. Ren, J. Sodroski, and X. Yang (2005)
J. Virol. 79, 5616-5624
 |  Abstract »  |  Full Text »  |  PDF »

Polyarginine Inhibits gp160 Processing by Furin and Suppresses Productive Human Immunodeficiency Virus Type 1 Infection.

K. V. Kibler, A. Miyazato, V. S. R. K. Yedavalli, A. I. Dayton, B. L. Jacobs, G. Dapolito, S.-j. Kim, and K.-T. Jeang (2004)
J. Biol. Chem. 279, 49055-49063
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of HIV-1 Envelope Glycoprotein-mediated Cell Fusion by a DL-Amino Acid-containing Fusion Peptide: POSSIBLE RECOGNITION OF THE FUSION COMPLEX.

D. Gerber, M. Pritsker, S. Gunther-Ausborn, B. Johnson, R. Blumenthal, and Y. Shai (2004)
J. Biol. Chem. 279, 48224-48230
 |  Abstract »  |  Full Text »  |  PDF »

Resistance to enfuvirtide, the first HIV fusion inhibitor.

M. L. Greenberg and N. Cammack (2004)
J. Antimicrob. Chemother. 54, 333-340
 |  Abstract »  |  Full Text »  |  PDF »

N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies.

R. A. McCaffrey, C. Saunders, M. Hensel, and L. Stamatatos (2004)
J. Virol. 78, 3279-3295
 |  Abstract »  |  Full Text »  |  PDF »

The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope.

M. K. Gorny, K. Revesz, C. Williams, B. Volsky, M. K. Louder, C. A. Anyangwe, C. Krachmarov, S. C. Kayman, A. Pinter, A. Nadas, et al. (2004)
J. Virol. 78, 2394-2404
 |  Abstract »  |  Full Text »  |  PDF »

Bystander Killing during Avian Leukosis Virus Subgroup B Infection Requires TVBS3 Signaling.

F. Diaz-Griffero, S. A. Hoschander, and J. Brojatsch (2003)
J. Virol. 77, 12552-12561
 |  Abstract »  |  Full Text »  |  PDF »

Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2'F-RNA Aptamers.

M. Khati, M. Schuman, J. Ibrahim, Q. Sattentau, S. Gordon, and W. James (2003)
J. Virol. 77, 12692-12698
 |  Abstract »  |  Full Text »  |  PDF »

Caprine Arthritis-Encephalitis Virus Envelope Surface Glycoprotein Regions Interacting with the Transmembrane Glycoprotein: Structural and Functional Parallels with Human Immunodeficiency Virus Type 1 gp120.

I. Hotzel and W. P. Cheevers (2003)
J. Virol. 77, 11578-11587
 |  Abstract »  |  Full Text »  |  PDF »

C-terminal Octylation Rescues an Inactive T20 Mutant: IMPLICATIONS FOR THE MECHANISM OF HIV/SIMIAN IMMUNODEFICIENCY VIRUS-INDUCED MEMBRANE FUSION.

S. G. Peisajovich, S. A. Gallo, R. Blumenthal, and Y. Shai (2003)
J. Biol. Chem. 278, 21012-21017
 |  Abstract »  |  Full Text »  |  PDF »

Novel Therapies Based on Mechanisms of HIV-1 Cell Entry.

J. M. Kilby and J. J. Eron (2003)
N. Engl. J. Med. 348, 2228-2238
 |  Full Text »  |  PDF »

Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages.

J. J. Kohler, D. L. Tuttle, C. R. Coberley, J. W. Sleasman, and M. M. Goodenow (2003)
J. Leukoc. Biol. 73, 407-416
 |  Abstract »  |  Full Text »  |  PDF »

Concordant Modulation of Neutralization Resistance and High Infectivity of the Primary Human Immunodeficiency Virus Type 1 MN Strain and Definition of a Potential gp41 Binding Site in gp120.

M. Leavitt, E. J. Park, I. A. Sidorov, D. S. Dimitrov, and G. V. Quinnan Jr. (2003)
J. Virol. 77, 560-570
 |  Abstract »  |  Full Text »  |  PDF »

Fine Mapping of the Interaction of Neutralizing and Nonneutralizing Monoclonal Antibodies with the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120.

R. Pantophlet, E. Ollmann Saphire, P. Poignard, P. W. H. I. Parren, I. A. Wilson, and D. R. Burton (2003)
J. Virol. 77, 642-658
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Point Mutations in the N Terminus of the Lentivirus Lytic Peptide-1 Sequence of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 on Env Stability.

S.-F. Lee, C.-Y. Ko, C.-T. Wang, and S. S.-L. Chen (2002)
J. Biol. Chem. 277, 15363-15375
 |  Abstract »  |  Full Text »  |  PDF »

Role of N-Linked Glycans in a Human Immunodeficiency Virus Envelope Glycoprotein: Effects on Protein Function and the Neutralizing Antibody Response.

M. I. Quinones-Kochs, L. Buonocore, and J. K. Rose (2002)
J. Virol. 76, 4199-4211
 |  Abstract »  |  Full Text »  |  PDF »

Mutations within the Putative Membrane-Spanning Domain of the Simian Immunodeficiency Virus Transmembrane Glycoprotein Define the Minimal Requirements for Fusion, Incorporation, and Infectivity.

J. T. West, P. B. Johnston, S. R. Dubay, and E. Hunter (2001)
J. Virol. 75, 9601-9612
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Soluble CD4 on Exposure of Epitopes on Primary, Intact, Native Human Immunodeficiency Virus Type 1 Virions of Different Genetic Clades.

H. A. Mbah, S. Burda, M. K. Gorny, C. Williams, K. Revesz, S. Zolla-Pazner, and P. N. Nyambi (2001)
J. Virol. 75, 7785-7788
 |  Abstract »  |  Full Text »  |  PDF »

Mutational Analysis of Conserved Domains within the Cytoplasmic Tail of gp41 from Human Immunodeficiency Virus Type 1: Effects on Glycoprotein Incorporation and Infectivity.

S. C. Piller, J. W. Dubay, C. A. Derdeyn, and E. Hunter (2000)
J. Virol. 74, 11717-11723
 |  Abstract »  |  Full Text »  |  PDF »

Recognition by Human Monoclonal Antibodies of Free and Complexed Peptides Representing the Prefusogenic and Fusogenic Forms of Human Immunodeficiency Virus Type 1 gp41.

M. K. Gorny and S. Zolla-Pazner (2000)
J. Virol. 74, 6186-6192
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of Stable, Soluble Trimers Containing Complete Ectodomains of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins.

X. Yang, M. Farzan, R. Wyatt, and J. Sodroski (2000)
J. Virol. 74, 5716-5725
 |  Abstract »  |  Full Text »  |  PDF »

Modifications That Stabilize Human Immunodeficiency Virus Envelope Glycoprotein Trimers in Solution.

X. Yang, L. Florin, M. Farzan, P. Kolchinsky, P. D. Kwong, J. Sodroski, and R. Wyatt (2000)
J. Virol. 74, 4746-4754
 |  Abstract »  |  Full Text »  |  PDF »

Envelope Glycoprotein Determinants of Increased Fusogenicity in a Pathogenic Simian-Human Immunodeficiency Virus (SHIV-KB9) Passaged In Vivo.

B. Etemad-Moghadam, Y. Sun, E. K. Nicholson, M. Fernandes, K. Liou, R. Gomila, J. Lee, and J. Sodroski (2000)
J. Virol. 74, 4433-4440
 |  Abstract »  |  Full Text »  |  PDF »

The SU and TM Envelope Protein Subunits of Bovine Leukemia Virus Are Linked by Disulfide Bonds, both in Cells and in Virions.

E. R. Johnston and K. Radke (2000)
J. Virol. 74, 2930-2935
 |  Abstract »  |  Full Text »  |  PDF »

Characterization of the Sequence of Interactions of the Fusion Domain of the Simian Immunodeficiency Virus with Membranes. ROLE OF THE MEMBRANE DIPOLE POTENTIAL.

J. Cladera, I. Martin, J.-M. Ruysschaert, and P. O'Shea (1999)
J. Biol. Chem. 274, 29951-29959
 |  Abstract »  |  Full Text »  |  PDF »

trans-Dominant Interference with Human Immunodeficiency Virus Type 1 Replication and Transmission in CD4+ Cells by an Envelope Double Mutant.

S. S.-L. Chen, S.-F. Lee, C.-K. Chuang, and V. S. Raj (1999)
J. Virol. 73, 8290-8302
 |  Abstract »  |  Full Text »  |  PDF »

Determinants of Neutralization Resistance in the Envelope Glycoproteins of a Simian-Human Immunodeficiency Virus Passaged In Vivo.

B. Etemad-Moghadam, Y. Sun, E. K. Nicholson, G. B. Karlsson, D. Schenten, and J. Sodroski (1999)
J. Virol. 73, 8873-8879
 |  Abstract »  |  Full Text »  |  PDF »

Cross-Subtype Neutralizing Antibodies Induced in Baboons by a Subtype E gp120 Immunogen Based on an R5 Primary Human Immunodeficiency Virus Type 1 Envelope.

T. C. VanCott, J. R. Mascola, L. D. Loomis-Price, F. Sinangil, N. Zitomersky, J. McNeil, M. L. Robb, D. L. Birx, and S. Barnett (1999)
J. Virol. 73, 4640-4650
 |  Abstract »  |  Full Text »  |  PDF »

T20/DP178, an Ectodomain Peptide of Human Immunodeficiency Virus Type 1 gp41, Is an Activator of Human Phagocyte N-Formyl Peptide Receptor.

S. B. Su, W.-h. Gong, J.-L. Gao, W.-P. Shen, M. C. Grimm, X. Deng, P. M. Murphy, J. J. Oppenheim, and J. M. Wang (1999)
Blood 93, 3885-3892
 |  Abstract »  |  Full Text »  |  PDF »

T21/DP107, A Synthetic Leucine Zipper-Like Domain of the HIV-1 Envelope gp41, Attracts and Activates Human Phagocytes by Using G-Protein-Coupled Formyl Peptide Receptors.

S. B. Su, J.-l. Gao, W.-h. Gong, N. M. Dunlop, P. M. Murphy, J. J. Oppenheim, and J. M. Wang (1999)
J. Immunol. 162, 5924-5930
 |  Abstract »  |  Full Text »  |  PDF »

Complete Sequence of Enzootic Nasal Tumor Virus, a Retrovirus Associated with Transmissible Intranasal Tumors of Sheep.

C. Cousens, E. Minguijon, R. G. Dalziel, A. Ortin, M. Garcia, J. Park, L. Gonzalez, J. M. Sharp, and M. de las Heras (1999)
J. Virol. 73, 3986-3993
 |  Abstract »  |  Full Text »  |  PDF »

Biophysical Characterization of the Structure of the Amino-terminal Region of gp41 of HIV-1. IMPLICATIONS ON VIRAL FUSION MECHANISM.

D.-K. Chang, S.-F. Cheng, and V. D. Trivedi (1999)
J. Biol. Chem. 274, 5299-5309
 |  Abstract »  |  Full Text »  |  PDF »

The YXXL Sequences of a Transmembrane Protein of Bovine Leukemia Virus Are Required for Viral Entry and Incorporation of Viral Envelope Protein into Virions.

K. Inabe, M. Nishizawa, S. Tajima, K. Ikuta, and Y. Aida (1999)
J. Virol. 73, 1293-1301
 |  Abstract »  |  Full Text »  |  PDF »

HIV-induced T-cell syncytia release a two component T-helper cell chemoattractant composed of Nef and Tat.

D. Shutt and D. Soll (1999)
J. Cell Sci. 112, 3931-3941
 |  Abstract »  |  PDF »

Characterization of Simian-Human Immunodeficiency Virus Envelope Glycoprotein Epitopes Recognized by Neutralizing Antibodies from Infected Monkeys.

B. Etemad-Moghadam, G. B. Karlsson, M. Halloran, Y. Sun, D. Schenten, M. Fernandes, N. L. Letvin, and J. Sodroski (1998)
J. Virol. 72, 8437-8445
 |  Abstract »  |  Full Text »  |  PDF »

Identification of an Erythrocyte Binding Peptide from the Erythrocyte Binding Antigen, EBA-175, Which Blocks Parasite Multiplication and Induces Peptide-Blocking Antibodies.

P. H. Jakobsen, P. M. H. Heegaard, C. Koch, K. Wasniowska, M. M. Lemnge, J. B. Jensen, and B. K. L. Sim (1998)
Infect. Immun. 66, 4203-4207
 |  Abstract »  |  Full Text »  |  PDF »

Dissociation of the CD4 and CXCR4 Binding Properties of Human Immunodeficiency Virus Type 1 gp120 by Deletion of the First Putative Alpha-Helical Conserved Structure.

D. Misse, M. Cerutti, I. Schmidt, A. Jansen, G. Devauchelle, F. Jansen, and F. Veas (1998)
J. Virol. 72, 7280-7288
 |  Abstract »  |  Full Text »  |  PDF »

Stabilization of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers by Disulfide Bonds Introduced into the gp41 Glycoprotein Ectodomain.

M. Farzan, H. Choe, E. Desjardins, Y. Sun, J. Kuhn, J. Cao, D. Archambault, P. Kolchinsky, M. Koch, R. Wyatt, et al. (1998)
J. Virol. 72, 7620-7625
 |  Abstract »  |  Full Text »  |  PDF »

Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies.

N. Sullivan, Y. Sun, J. Binley, J. Lee, C. F. Barbas III, P. W. H. I. Parren, D. R. Burton, and J. Sodroski (1998)
J. Virol. 72, 6332-6338
 |  Abstract »  |  Full Text »  |  PDF »

Expression of the Extracellular Domain of the Human Immunodeficiency Virus Type 1 Envelope Protein and Its Fusion with beta -Galactosidase in Saccharomyces cerevisiae.

W.-F. Liu, D. Gao, and Z.-N. Wang (1998)
Clin. Vaccine Immunol. 5, 592-594
 |  Abstract »  |  Full Text »  |  PDF »

Functional Domains in the Retroviral Transmembrane Protein.

Y. Zhao, L. Zhu, C. A. Benedict, D. Chen, W. F. Anderson, and P. M. Cannon (1998)
J. Virol. 72, 5392-5398
 |  Abstract »  |  Full Text »  |  PDF »

A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.

M. Pritsker, P. Jones, R. Blumenthal, and Y. Shai (1998)
PNAS 95, 7287-7292
 |  Abstract »  |  Full Text »  |  PDF »

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens.

R. Wyatt and J. Sodroski (1998)
Science 280, 1884-1888
 |  Abstract »  |  Full Text »

Mutation-Directed Chemical Cross-Linking of Human Immunodeficiency Virus Type 1 gp41 Oligomers.

T. L. McInerney, W. El Ahmar, B. E. Kemp, and P. Poumbourios (1998)
J. Virol. 72, 1523-1533
 |  Abstract »  |  Full Text »  |  PDF »

Mutational Analysis of the Fusion Peptide of Moloney Murine Leukemia Virus Transmembrane Protein p15E.

N.-L. Zhu, P. M. Cannon, D. Chen, and W. F. Anderson (1998)
J. Virol. 72, 1632-1639
 |  Abstract »  |  Full Text »  |  PDF »

Use of Murine CXCR-4 as a Second Receptor by Some T-Cell-Tropic Human Immunodeficiency Viruses.

C. Parolin, A. Borsetti, H. Choe, M. Farzan, P. Kolchinsky, M. Heesen, Q. Ma, C. Gerard, G. Palu, M. E. Dorf, et al. (1998)
J. Virol. 72, 1652-1656
 |  Abstract »  |  Full Text »  |  PDF »

Dilation of the Human Immunodeficiency Virus-1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41.

I. Munoz-Barroso, S. Durell, K. Sakaguchi, E. Appella, and R. Blumenthal (1998)
J. Cell Biol. 140, 315-323
 |  Abstract »  |  Full Text »  |  PDF »

Identification of a CD36-related Thrombospondin 1-binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1-specific Inhibitory Factors in Human Saliva.

R. Crombie, R. L. Silverstein, C. MacLow, S. F. A. Pearce, R. L. Nachman, and J. Laurence (1998)
J. Exp. Med. 187, 25-35
 |  Abstract »  |  Full Text »  |  PDF »

T cell syncytia induced by HIV release. T cell chemoattractants: demonstration with a newly developed single cell chemotaxis chamber.

D. Shutt, L. Jenkins, E. Carolan, J Stapleton, K. Daniels, R. Kennedy, and D. Soll (1998)
J. Cell Sci. 111, 99-109
 |  Abstract »  |  PDF »

CD4-Independent Binding of SIV gp120 to Rhesus CCR5.

K. A. Martin, R. Wyatt, M. Farzan, H. Choe, L. Marcon, E. Desjardins, J. Robinson, J. Sodroski, C. Gerard, and N. P. Gerard (1997)
Science 278, 1470-1473
 |  Abstract »  |  Full Text »

Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection.

M. Farzan, H. Choe, K. Martin, L. Marcon, W. Hofmann, G. Karlsson, Y. Sun, P. Barrett, N. Marchand, N. Sullivan, et al. (1997)
J. Exp. Med. 186, 405-411
 |  Abstract »  |  Full Text »  |  PDF »

Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli.

W. Weissenhorn, L. J. Calder, A. Dessen, T. Laue, J. J. Skehel, and D. C. Wiley (1997)
PNAS 94, 6065-6069
 |  Abstract »  |  Full Text »  |  PDF »

Identification of the Paired Basic Convertases Implicated in HIV gp160 Processing Based on in Vitro Assays and Expression in CD4+ Cell Lines.

E. Decroly, S. Wouters, C. Di Bello, C. Lazure, J.-M. Ruysschaert, and N. G. Seidah (1996)
J. Biol. Chem. 271, 30442-30450
 |  Abstract »  |  Full Text »  |  PDF »

A Synthetic Conformational Epitope from the C4 Domain of HIV Gp120 That Binds CD4.

F. A. Robey, T. Harris-Kelson, M. Robert-Guroff, B. Ivanov, M. S. Lewis, and P. P. Roller (1996)
J. Biol. Chem. 271, 17990-17995
 |  Abstract »  |  Full Text »  |  PDF »

The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection.

E. O. Freed and M. A. Martin (1995)
J. Biol. Chem. 270, 23883-23886
 |  Full Text »  |  PDF »

A Helical Epitope in the C4 Domain of HIV Glycoprotein 120.

F. A. Robey, T. Kelson-Harris, P. P. Roller, and M. Robert-Guroff (1995)
J. Biol. Chem. 270, 23918-23921
 |  Abstract »  |  Full Text »  |  PDF »

Biochemical and Genetic Definition of the Cellular Protease Required for HIV-1 gp160 Processing.

A. Franzusoff, A. M. Volpe, D. Josse, S. Pichuantes, and J. R. Wolf (1995)
J. Biol. Chem. 270, 3154-3159
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

J. Harouse, S Bhat, S. Spitalnik, M Laughlin, K Stefano, D. Silberberg, and F Gonzalez-Scarano (1991)
Science 253, 320-323
 |  Abstract »  |  PDF »

Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

J. Moore, J. McKeating, R. Weiss, and Q. Sattentau (1990)
Science 250, 1139-1142
 |  Abstract »  |  PDF »

Functional analysis of CAR, the target sequence for the Rev protein of HIV-1.

E. Dayton, D. Powell, and A. Dayton (1989)
Science 246, 1625-1629
 |  Abstract »  |  PDF »

Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation.

J. Hildreth and R. Orentas (1989)
Science 244, 1075-1078
 |  Abstract »  |  PDF »

Prospects for Prevention of and Early Intervention Against HIV.

D. P. Bolognesi (1989)
JAMA 261, 3007-3013
 |  Abstract »  |  PDF »

Identification of the fusion peptide of primate immunodeficiency viruses.

M. Bosch, P. Earl, K Fargnoli, S Picciafuoco, F Giombini, F Wong-Staal, and G Franchini (1989)
Science 244, 694-697
 |  Abstract »  |  PDF »

Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection.

A. S. Fauci, R. C. Gallo, S. Koenig, J. Salk, and R. H. Purcell (1989)
Ann Intern Med 110, 373-385
 |  Abstract »  |  PDF »

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity.

J. Lifson, K. Hwang, P. Nara, B Fraser, M Padgett, N. Dunlop, and L. Eiden (1988)
Science 241, 712-716
 |  Abstract »  |  PDF »

Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.

B. Jameson, P. Rao, L. Kong, B. Hahn, G. Shaw, L. Hood, and S. Kent (1988)
Science 240, 1335-1339
 |  Abstract »  |  PDF »

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells.

H Mitsuya, D. Looney, S Kuno, R Ueno, F Wong-Staal, and S Broder (1988)
Science 240, 646-649
 |  Abstract »  |  PDF »

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.

D. Ho, J. Kaplan, I. Rackauskas, and M. Gurney (1988)
Science 239, 1021-1023
 |  Abstract »  |  PDF »

Multimerization Potential of the Cytoplasmic Domain of the Human Immunodeficiency Virus Type 1 Transmembrane Glycoprotein gp41.

S.-F. Lee, C.-T. Wang, J. Y.-P. Liang, S.-L. Hong, C.-C. Huang, and S. S.-L. Chen (2000)
J. Biol. Chem. 275, 15809-15819
 |  Abstract »  |  Full Text »  |  PDF »

Mode of Action of an Antiviral Peptide from HIV-1. INHIBITION AT A POST-LIPID MIXING STAGE.

Y. Kliger, S. A. Gallo, S. G. Peisajovich, I. Munoz-Barroso, S. Avkin, R. Blumenthal, and Y. Shai (2001)
J. Biol. Chem. 276, 1391-1397
 |  Abstract »  |  Full Text »  |  PDF »

Early Intermediates in HIV-1 Envelope Glycoprotein-mediated Fusion Triggered by CD4 and Co-receptor Complexes.

A. S. Dimitrov, X. Xiao, D. S. Dimitrov, and R. Blumenthal (2001)
J. Biol. Chem. 276, 30335-30341
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products